NCT07613281
Serene Sleep Palatal Implant System Clinical Confirmatory Trial in Participants Who Snore or Are Diagnosed With Mild-to-moderate Obstructive Sleep Apnea (OSA).
StatusEnrolling by Invitation
PhaseNot applicable
SponsorSerene Sleep, Inc.
Primary completion (estimated)
At risk: Primary completion moved at least 32 days later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Enrolling by invitation only Show 6 more changesShow less
- Eligibility criteria expanded, about 41 words
- Primary completion pushed from Sep 2026 to Nov 2026
- Study completion date: Oct 2026 to Nov 2026
- Start date changed from estimate of Jun 2026 to Jun 17, 2026
- Secondary endpoints: details revised at 1 of 2 entries
- Site contacts updated at 2 of 2 sites
Notable Phase changed: Not specified → Not applicablev2 Show 9 more changesShow less
- Primary endpoint(s) modified
- Sponsor changed: [Redacted] to Serene Sleep, Inc.
- Trial status changed: Withheld → Not Yet Recruiting
- Enrollment changed: None → 26
- Trial arms changed: 0 → 2
- Primary completion date: Sep 2026
- Study completion date: Oct 2026
- Start date: Jun 2026
- Study title expanded, about 8 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Proportion of Participants with Implant Extrusion at 30 Days and Absence of Serious Adverse Device Effects (SADEs) [Hybrid Composite Safety Endpoint]
Timeframe: From baseline to 30 days post-procedure
Secondary (2)
Change is Visual Analogue Scale (VAS) Score
Change in Snoring Outcomes Survey (SOS)
Arms and interventions
Snoring GroupExperimental
Implant with the Serene Sleep Palatal Implant System
Mild to Moderate OSA GroupExperimental
Implant with the Serene Sleep Palatal Implant System
Devices: Palatal Implant System
Sites
2 sites in 1 country